tiprankstipranks
Trending News
More News >

Biophytis Raises €2.6 Million to Boost Clinical Programs

Story Highlights
Biophytis Raises €2.6 Million to Boost Clinical Programs

Don’t Miss TipRanks’ Half-Year Sale

An announcement from Biophytis SA ( (FR:ALBPS) ) is now available.

Biophytis SA has successfully raised approximately 2.6 million euros through a private placement, issuing new shares and pre-funded share subscription warrants. The funds will be used to accelerate the development of their clinical programs, particularly for BIO101 in obesity and sarcopenia, support regulatory activities, and extend the company’s cash flow until the third quarter of 2025, reflecting investor confidence in Biophytis’s strategic direction and potential.

More about Biophytis SA

Biophytis SA is a clinical-stage biotechnology company focused on developing treatments for age-related diseases. The company is engaged in advancing clinical programs aimed at addressing significant unmet medical needs, particularly in the areas of obesity and sarcopenia.

YTD Price Performance: -16.00%

Average Trading Volume: 18,486

Technical Sentiment Signal: Buy

Current Market Cap: €4.33M

Learn more about ALBPS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1